Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.60 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.60 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1723411 | 0.98 | CHRM2 (0.58) | CHRM2CHRM4CHRM5LMNAHRH3 | |
| SCHEMBL5728905 | 0.98 | CHRM2 (0.58) | CHRM2CHRM4CHRM5LMNAHRH3 | |
| Ammonia Solution, Strong SCHEMBL8187341 | 0.98 | CHRM2 (0.58) | CHRM2CHRM4CHRM5LMNAHRH3 | |
| Ammonia Solution, Strong SCHEMBL18049528 | 0.92 | CHRM2 (0.56) | CHRM2CHRM4CHRM5LMNAHRH3 | |
| SCHEMBL20483452 | 0.91 | CHRM2 (0.64) | CHRM2CHRM4CHRM5HRH3KMT2A | |
| Methylamine SCHEMBL4437029 | 0.88 | CHRM2 (0.53) | CHRM2CHRM4CHRM5LMNAHRH3 | |
| SCHEMBL6067796 | 0.88 | CHRM2 (0.53) | CHRM2CHRM4CHRM5LMNAHRH3 | |
| SCHEMBL637410 | 0.87 | CHRM2 (0.51) | CHRM2CHRM4CHRM5LMNAKMT2A | |
| SCHEMBL12564502 | 0.87 | CHRM2 (0.56) | CHRM2CHRM4CHRM5LMNAHRH3 | |
| SCHEMBL15425876 | 0.85 | KMT2A (0.54) | CHRM2CHRM4CHRM5LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115093549-A | Polythiophene with side chain containing ABNO, and preparation method and application thereof | 浙江吉泰新材料股份有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-115073714-A | Polycarbazole with side chain containing nitroxide free radical and preparation method and application thereof | 浙江吉泰新材料股份有限公司 | 2022-09-20 | — | — | CN | claimed |
| EP-0861252-B1 | NAPHTHAMIDE DERIVATIVES OF 3 BETA-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS | PF MEDICAMENT (FR) | 2000-02-23 | — | — | EP | claimed |
| CN-115093549-A | Polythiophene with side chain containing ABNO, and preparation method and application thereof | 浙江吉泰新材料股份有限公司 | 2022-09-23 | — | — | CN | disclosed |
| CN-115073714-A | Polycarbazole with side chain containing nitroxide free radical and preparation method and application thereof | 浙江吉泰新材料股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-7420088-B2 | Method for the production of formic acid | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-02 | — | — | US | disclosed |
| US-20080097126-A1 | Method for the Production of Formic Acid | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-24 | — | — | US | disclosed |
| EP-1784375-A1 | METHOD FOR THE PRODUCTION OF FORMIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-16 | — | — | EP | disclosed |
| WO-2006021411-A1 | METHOD FOR THE PRODUCTION OF FORMIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-02 | — | — | WO | disclosed |
| EP-0861252-B1 | NAPHTHAMIDE DERIVATIVES OF 3 BETA-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS | PF MEDICAMENT (FR) | 2000-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080097126-A1 | Method for the Production of Formic Acid | F5, F7, F2 | CHRM2 3359/4885CHRM4 2833/4885CHRM5 1814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.